Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommaso Ceruti

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecules (Basel, Switzerland)|February 15, 2022
Pharmacokinetic Characterization of the DDAH1 Inhibitors ZST316 and ZST152 in Mice Using a HPLC-MS/MS MethodArduino A Mangoni, Tommaso Ceruti, Roberta Frapolli, et al.
Molecules (Basel, Switzerland)|December 23, 2023
Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in MiceTommaso Ceruti, Roberta Frapolli, Carmen Ghilardi, et al.
Journal of Photochemistry and Photobiology. B, Biology|October 10, 2021
Betulinic acid and its spray dried microparticle formulation: In vitro PDT effect against ovarian carcinoma cell line and in vivo plasma and tumor dispositionAlessandra F Serain, Lavinia Morosi, Tommaso Ceruti, et al.
Cells|April 17, 2020
CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with ChemotherapyAndrea Resovi, Patrizia Borsotti, Tommaso Ceruti, et al.
International Journal of Biological Sciences|March 27, 2020
Quantitative determination of niraparib and olaparib tumor distribution by mass spectrometry imagingLavinia Morosi, Cristina Matteo, Tommaso Ceruti, et al.
Talanta|November 5, 2021
Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imagingLavinia Morosi, Cristina Matteo, Marina Meroni, et al.
Pharmaceutics|October 27, 2022
Development and Validation of a HPLC-MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing MiceTommaso Ceruti, Quintino Giorgio D'Alessandris, Roberta Frapolli, et al.
Pediatric Blood & Cancer|May 13, 2022
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase productCristina Matteo, Antonella Colombini, Laura Rachele Bettini, et al.
Targeted Oncology|December 28, 2020
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic ProfileDomenica Lorusso, Giuseppa Maltese, Ilaria Sabatucci, et al.
Science Translational Medicine|February 28, 2020
High-dose vitamin C enhances cancer immunotherapyAlessandro Magrì, Giovanni Germano, Annalisa Lorenzato, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|February 15, 2022
Pharmacokinetic Characterization of the DDAH1 Inhibitors ZST316 and ZST152 in Mice Using a HPLC-MS/MS MethodArduino A Mangoni, Tommaso Ceruti, Roberta Frapolli, et al.
Molecules (Basel, Switzerland)|December 23, 2023
Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in MiceTommaso Ceruti, Roberta Frapolli, Carmen Ghilardi, et al.
Journal of Photochemistry and Photobiology. B, Biology|October 10, 2021
Betulinic acid and its spray dried microparticle formulation: In vitro PDT effect against ovarian carcinoma cell line and in vivo plasma and tumor dispositionAlessandra F Serain, Lavinia Morosi, Tommaso Ceruti, et al.
Cells|April 17, 2020
CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with ChemotherapyAndrea Resovi, Patrizia Borsotti, Tommaso Ceruti, et al.
International Journal of Biological Sciences|March 27, 2020
Quantitative determination of niraparib and olaparib tumor distribution by mass spectrometry imagingLavinia Morosi, Cristina Matteo, Tommaso Ceruti, et al.
Talanta|November 5, 2021
Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imagingLavinia Morosi, Cristina Matteo, Marina Meroni, et al.
Pharmaceutics|October 27, 2022
Development and Validation of a HPLC-MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing MiceTommaso Ceruti, Quintino Giorgio D'Alessandris, Roberta Frapolli, et al.
Pediatric Blood & Cancer|May 13, 2022
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase productCristina Matteo, Antonella Colombini, Laura Rachele Bettini, et al.
Targeted Oncology|December 28, 2020
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic ProfileDomenica Lorusso, Giuseppa Maltese, Ilaria Sabatucci, et al.
Science Translational Medicine|February 28, 2020
High-dose vitamin C enhances cancer immunotherapyAlessandro Magrì, Giovanni Germano, Annalisa Lorenzato, et al.
Pageof 2